Cargando…

Text messaging interventions to support smoking cessation among hospitalized patients in Brazil: a randomized comparative effectiveness clinical trial

OBJECTIVE: A clinical trial carried out in patients hospitalized for clinical and surgical conditions. This study evaluated the effectiveness of text messaging interventions (TM) versus telephone counseling (TC) to promote smoking cessation among hospitalized smokers in a middle-income country. Seve...

Descripción completa

Detalles Bibliográficos
Autores principales: do Amaral, Lígia Menezes, Ronzani, Telmo Mota, Cruvinel, Erica, Richter, Kimber, Oliveira Andrade, Rafaela de, Lanzieri, Isabella Oliveira, de Macêdo, Ângela Caroline Dias Albino Destro, Leite, Isabel Cristina Gonçalves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962029/
https://www.ncbi.nlm.nih.gov/pubmed/35346351
http://dx.doi.org/10.1186/s13104-022-06002-6
Descripción
Sumario:OBJECTIVE: A clinical trial carried out in patients hospitalized for clinical and surgical conditions. This study evaluated the effectiveness of text messaging interventions (TM) versus telephone counseling (TC) to promote smoking cessation among hospitalized smokers in a middle-income country. Seven-day abstinence was measured during follow-up phone calls one month after discharge. The comparative cost of the two interventions considered the cost of calls, time spent on phone calls and sending SMS and cost of the professional involved in the approaches. RESULTS: Past 7-day tobacco abstinence was not statistically different between groups (30.5% in TM group and 26% in TC, p = 0.318). Costs were significantly lower in the TM group (U$9.28 × U$19.45- p < 0,001). Continuous abstinence was reported by 26% of TM participants and 24.5% of TC participants (p = 0.730). In the 3-month follow-up, 7-day abstinence was 23% in the TMI and 27% in the TC (p = 0.356) group. Continuous abstinence was reported by 20% of TM participants and 24% of TC participants (p = 0.334). Trial registration: ClinicalTrials.gov ID: NCT03237949 Registred on: 30th May 2017. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13104-022-06002-6.